本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aerovate Therapeutics, Inc.

9.80
+0.0000
成交量:- -
成交額:- -
市值:2.84億
市盈率:-5.76
高:9.80
開:9.80
低:9.80
收:9.80
資料載入中...
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/17

重要事件披露

Form 8-K - Current report
2024/10/10

重要事件披露

Form 8-K - Current report
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/08

重要事件披露

Form 8-K - Current report
2024/07/01

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities